FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to an immune-inducing composition containing polypeptide MCEMP1 with an amino acid sequence with SEQ ID NO: 2 or 8; it can be used in medicine.
EFFECT: obtained composition can be used for the effective therapy of MCEMP1-expressing cancer.
6 cl, 3 dwg, 2 ex
| Title |
Year |
Author |
Number |
| IMMUNO-INDUCING AGENT |
2016 |
- Kurihara Akira
- Okano Fumiyoshi
|
RU2744843C2 |
| IMMUNITY INDUCER |
2016 |
- Kurihara Akira
- Okano Fumiyoshi
|
RU2758112C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMORS |
2017 |
- Fujita Takayuki
- Okano Fumiyoshi
|
RU2755894C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT TUMOUR |
2016 |
- Okano, Fumiyoshi
- Fujita, Takayuki
- Chon, Hyongi
- Kurihara, Akira
|
RU2714205C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR |
2017 |
- Okano, Fumiesi
- Saito, Takanori
|
RU2766586C2 |
| PEPTIDE DERIVED FROM FOXM1, AND INCLUDING ITS VACCINE |
2016 |
- Yamashita, Sachiko
- Hikichi, Tetsuro
|
RU2738418C2 |
| IMMUNE TOLERANCE INDUCING ANTIBODIES, INDUCED LYMPHOCYTES AND THERAPEUTIC AGENT/METHOD OF CELL THERAPY USING INDUCED LYMPHOCYTES |
2019 |
- Maeda Ryu
- Kawakami Masayuki
- Uchida Koichiro
- Takeda Kazuyoshi
- Okumura Ko
|
RU2816592C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR |
2019 |
- Okano, Fumiyoshi
- Saito, Takanori
|
RU2781542C2 |
| ANTIBODY TO HUMAN CD73 |
2017 |
- Sato, Masakhito
- Tojonaga, Khanae
- Osaki, Fumio
- Eguchi, Tomokhiro
|
RU2754058C2 |
| METHOD FOR PRODUCING CHEMICAL PRODUCTS OF SUBTLE SYNTHESIS USING CORYNEBACTERIUM SECRETING MODIFIED a-1,6-GLUCOSIDASES |
2018 |
- Voss, Kornelia
- Voss, Michaela
- Thierbach, Georg
|
RU2763317C2 |
